Moez Kassam is 10% Owner at MEI Pharma, Inc. (MEIP). They have made 1 open-market trade across 1 company since 2023, most recently 2023-10-20.
CIK 0001585167
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $938K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MEIP | 1,057,388 | $3.2M |
Shares reported on the most recent Form 4, priced at the 2023-10-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MEIP | BUY | 2023-09-20 | 2023-09-22 | $6.11 | $938K | -13.1% | -8.5% | -20.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.